Logo image of NMS

NUVEEN MN QLTY MUNI INC (NMS) Stock Price, Quote, News and Overview

NYSE:NMS - New York Stock Exchange, Inc. - US6707341029 - Currency: USD

11.36  -0.02 (-0.18%)

Fundamental Rating

2

Overall NMS gets a fundamental rating of 2 out of 10. We evaluated NMS against 0 industry peers in the Unkown industry. NMS has a bad profitability rating. Also its financial health evaluation is rather negative. NMS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year NMS was profitable.
In the past year NMS had a positive cash flow from operations.
In multiple years NMS reported negative net income over the last 5 years.
NMS had a positive operating cash flow in each of the past 5 years.
NMS Yearly Net Income VS EBIT VS OCF VS FCFNMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

Industry RankSector Rank
ROA 4.82%
ROE 8.12%
ROIC 1.46%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NMS Yearly ROA, ROE, ROICNMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

NMS's Profit Margin has declined in the last couple of years.
NMS's Operating Margin has declined in the last couple of years.
NMS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 42.43%
PM (TTM) 110.84%
GM 44.11%
OM growth 3Y-33.03%
OM growth 5Y-18.03%
PM growth 3Y-32.81%
PM growth 5Y-16.88%
GM growth 3Y-31.46%
GM growth 5Y-16.9%
NMS Yearly Profit, Operating, Gross MarginsNMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

More info and screens

3

2. Health

2.1 Basic Checks

NMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NMS Yearly Shares OutstandingNMS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
NMS Yearly Total Debt VS Total AssetsNMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M

2.2 Solvency

NMS has an Altman-Z score of 0.83. This is a bad value and indicates that NMS is not financially healthy and even has some risk of bankruptcy.
The Debt to FCF ratio of NMS is 9.14, which is on the high side as it means it would take NMS, 9.14 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.68 indicates that NMS is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 9.14
Altman-Z 0.83
ROIC/WACCN/A
WACCN/A
NMS Yearly LT Debt VS Equity VS FCFNMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 5.67 indicates that NMS has no problem at all paying its short term obligations.
NMS has a Quick Ratio of 5.67. This indicates that NMS is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 5.67
Quick Ratio 5.67
NMS Yearly Current Assets VS Current LiabilitesNMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 264.29% over the past year.
The earnings per share for NMS have been decreasing by -22.02% on average. This is quite bad
The Revenue has grown by 52.42% in the past year. This is a very strong growth!
The Revenue has been decreasing by -6.36% on average over the past years.
EPS 1Y (TTM)264.29%
EPS 3Y-39.15%
EPS 5Y-22.02%
EPS Q2Q%875%
Revenue 1Y (TTM)52.42%
Revenue growth 3Y-9.6%
Revenue growth 5Y-6.36%
Sales Q2Q%109.45%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NMS Yearly Revenue VS EstimatesNMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.14, the valuation of NMS can be described as reasonable.
The average S&P500 Price/Earnings ratio is at 26.29. NMS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.14
Fwd PE N/A
NMS Price Earnings VS Forward Price EarningsNMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 12.28
EV/EBITDA N/A
NMS Per share dataNMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.10%, NMS is a good candidate for dividend investing.
NMS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 7.1%

5.2 History

NMS has paid a dividend for at least 10 years, which is a reliable track record.
NMS has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
NMS Yearly Dividends per shareNMS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

65.77% of the earnings are spent on dividend by NMS. This is not a sustainable payout ratio.
DP65.77%
EPS Next 2YN/A
EPS Next 3YN/A
NMS Yearly Income VS Free CF VS DividendNMS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M
NMS Dividend Payout.NMS Dividend Payout, showing the Payout Ratio.NMS Dividend Payout.PayoutRetained Earnings

More info and screens

NUVEEN MN QLTY MUNI INC

NYSE:NMS (6/2/2025, 8:25:38 PM)

11.36

-0.02 (-0.18%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners8.29%
Inst Owner Change16.8%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap66.91M
Analysts0
Price TargetN/A
Short Float %0.24%
Short Ratio0.87
Dividend
Industry RankSector Rank
Dividend Yield 7.1%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP65.77%
Div Incr Years1
Div Non Decr Years1
Ex-Date05-15 2025-05-15 (0.0735)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.14
Fwd PE N/A
P/S 12.51
P/FCF 12.28
P/OCF 12.28
P/B 0.92
P/tB 0.92
EV/EBITDA N/A
EPS(TTM)1.02
EY8.98%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.93
FCFY8.15%
OCF(TTM)0.93
OCFY8.15%
SpS0.91
BVpS12.39
TBVpS12.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.82%
ROE 8.12%
ROCE 1.85%
ROIC 1.46%
ROICexc 1.46%
ROICexgc 1.46%
OM 42.43%
PM (TTM) 110.84%
GM 44.11%
FCFM 101.87%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-33.03%
OM growth 5Y-18.03%
PM growth 3Y-32.81%
PM growth 5Y-16.88%
GM growth 3Y-31.46%
GM growth 5Y-16.9%
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 9.14
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.06
Cash Conversion N/A
Profit Quality 91.91%
Current Ratio 5.67
Quick Ratio 5.67
Altman-Z 0.83
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)264.29%
EPS 3Y-39.15%
EPS 5Y-22.02%
EPS Q2Q%875%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)52.42%
Revenue growth 3Y-9.6%
Revenue growth 5Y-6.36%
Sales Q2Q%109.45%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y336.54%
EBIT growth 3Y-39.46%
EBIT growth 5Y-23.24%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-16.15%
FCF growth 3Y-2.51%
FCF growth 5Y-6.06%
OCF growth 1Y-16.15%
OCF growth 3Y-2.51%
OCF growth 5Y-6.06%